Cell & Gene Therapy - Can Tissue Engineering and Regenerative Medicine Reverse Spinal Cord Injuries?
View as a Web Page
News Medical
 
  Cell & Gene Therapy Cell & Gene Therapy logo  
  The latest stem cells news from News Medical  
 

Newly Launched resDetectTM dsRNA ELISA KitNewly Launched resDetectTM dsRNA ELISA Kit

During the in vitro transcription (IVT) of mRNA products, Double-Stranded RNA (dsRNA) is frequently generated as a by-product, impacting vaccine safety and effectiveness.

Ensure the quality of mRNA products with the high-sensitivity dsRNA ELISA Kit! With a detection limit of 8.988 pg/mL, this kit ensures the quality and safety of mRNA products by specifically identifying dsRNA without cross-reacting with ssRNA or dsDNA. The Kit recognizes >40 bp dsRNA (including modified types) and is ideal for precise and reliable quality control of RNA products.

Secure Your Product Quality
 
   CellVoyant's AI-Powered Vision for the Future of Cell TherapyCellVoyant's AI-Powered Vision for the Future of Cell Therapy
 
CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making it more accessible and efficient.
 
   Can Tissue Engineering and Regenerative Medicine Reverse Spinal Cord Injuries?Can Tissue Engineering and Regenerative Medicine Reverse Spinal Cord Injuries?
 
Advances in tissue engineering offer hope for spinal cord injury repair, utilizing biomaterials, stem cells, and bioactive molecules to promote regeneration.
 
 Stem cell therapy shows promise for treating advanced Parkinson's disease
 
Stem cell therapy shows promise for treating advanced Parkinson's diseaseA stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical trial reported in Nature.
 
 
 Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumors
 
Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumorsB-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it can affect people of any age.
 
 
 Breakthrough Delivery System Advances CRISPR-Based Treatments
 
Breakthrough Delivery System Advances CRISPR-Based TreatmentsA research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than before.
 
 
 Scientists Build Live African Swine Fever Virus From Synthetic DNA Using CRISPR
 
Scientists Build Live African Swine Fever Virus From Synthetic DNA Using CRISPRUtilizing CRISPR-Cas9, scientists reconstitute live African swine fever virus from synthetic genomes, accelerating vaccine development for this deadly virus.
 
 
 DNA Aptamers Offer Precision Attack Against Leukemia Stem Cells
 
DNA Aptamers Offer Precision Attack Against Leukemia Stem CellsDrug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers at the University of Illinois Urbana-Champaign report.
 
 
    MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.
 

Use this GPT to search for edited and trustworthy references, articles, and equipment reviews from over 20 years of trusted medical and healthcare content.

Currently only available to ChatGPT Plus account holders.


 
Ask a Question Now
 
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025